Loading clinical trials...
Loading clinical trials...
Managed Access Program (MAP) Cohort Treatment Plan [CAAA617A12001M] to Provide Access to 177Lu-PSMA-617 for Patients With Metastatic Castration-resistant Prostate Cancer.
Conditions
Interventions
177Lu-PSMA-617
PSMA-11
Last Updated
January 13, 2023
NCT06615752
NCT06004661
NCT03972657
NCT06134232
NCT06241846
NCT06344715
Lead Sponsor
Advanced Accelerator Applications
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions